BRNS
Barinthus Biotherapeutics
BRNS
BRNS
11 hedge funds and large institutions have $15.7M invested in Barinthus Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
11
Holding in Top 10
1
Calls
–
Puts
–
Top Sellers
| 1 | -$1.19M | |
| 2 | -$97.7K | |
| 3 | -$52.7K | |
| 4 |
Morgan Stanley
New York
|
-$3.95K |